Anas Alshishani

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 5

Top Topics

Respiratory Syndrome Coronavirus

Induced Pluripotent Stem Cells

Room Temperature

Photodynamic Therapy

Top Venues

The Journal of pharmacy and pharmacology

Nanomaterials (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Rana Abutaima, Yousef Al-Ebini, Ahmad Alkofahi, Anas Alshishani, Samar Thiab, Kumarappan C Alagammai, Mohammad Khalid
In vivo assessment of black seed oil single dose on prednisolone pharmacokinetics. The Journal of pharmacy and pharmacology (2023)
Haneen A Basheer, Maram A Alhusban, Ahlam Zaid Alkilani, Anas Alshishani, Lina M Elsalem, Kamyar Afarinkia
Niosomal Delivery of Celecoxib and Metformin for Targeted Breast Cancer Treatment. Cancers 15 (20) (2023)
Yahya Alhamhoom, Abhay Sharma, Shivakumar Hagalavadi Nanjappa, Avichal Kumar, Anas Alshishani, Mohammed Muqtader Ahmed, Syeda Ayesha Farhana, Mohamed Rahamathulla
Development and Evaluation of Solid Dispersion-Based Sublingual Films of Nisoldipine. Pharmaceuticals (Basel, Switzerland) 16 (11) (2023)
Ahlam Zaid Alkilani, Hana Abu-Zour, Anas Alshishani, Rana Abu-Huwaij, Haneen A Basheer, Hadeel Abo-Zour
Formulation and Evaluation of Niosomal Alendronate Sodium Encapsulated in Polymeric Microneedles: In Vitro Studies, Stability Study and Cytotoxicity Study. Nanomaterials (Basel, Switzerland) 12 (20) (2022)
Mohammad Khalid, Anas Alshishani, Yousef Al-Ebini
Genome Similarities between Human-Derived and Mink-Derived SARS-CoV-2 Make Mink a Potential Reservoir of the Virus. Vaccines 10 (8) (2022)